Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

130 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Targeting the TGF beta signaling network in human neoplasia.
Dumont N, Arteaga CL. Dumont N, et al. Cancer Cell. 2003 Jun;3(6):531-6. doi: 10.1016/s1535-6108(03)00135-1. Cancer Cell. 2003. PMID: 12842082 Review. No abstract available.
Knockdown of the transforming growth factor-beta type III receptor impairs motility and invasion of metastatic cancer cells.
Criswell TL, Dumont N, Barnett JV, Arteaga CL. Criswell TL, et al. Among authors: dumont n. Cancer Res. 2008 Sep 15;68(18):7304-12. doi: 10.1158/0008-5472.CAN-07-6777. Cancer Res. 2008. PMID: 18794117
Dual role of transforming growth factor beta in mammary tumorigenesis and metastatic progression.
Muraoka-Cook RS, Dumont N, Arteaga CL. Muraoka-Cook RS, et al. Among authors: dumont n. Clin Cancer Res. 2005 Jan 15;11(2 Pt 2):937s-43s. Clin Cancer Res. 2005. PMID: 15701890 Review.
Overexpression of HER2 (erbB2) in human breast epithelial cells unmasks transforming growth factor beta-induced cell motility.
Ueda Y, Wang S, Dumont N, Yi JY, Koh Y, Arteaga CL. Ueda Y, et al. Among authors: dumont n. J Biol Chem. 2004 Jun 4;279(23):24505-13. doi: 10.1074/jbc.M400081200. Epub 2004 Mar 24. J Biol Chem. 2004. PMID: 15044465
TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia.
Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell S, Washington MK, Neilson EG, Moses HL. Bhowmick NA, et al. Among authors: dumont n. Science. 2004 Feb 6;303(5659):848-51. doi: 10.1126/science.1090922. Science. 2004. PMID: 14764882
A kinase-inactive type II TGFbeta receptor impairs BMP signaling in human breast cancer cells.
Dumont N, Arteaga CL. Dumont N, et al. Biochem Biophys Res Commun. 2003 Jan 31;301(1):108-12. doi: 10.1016/s0006-291x(02)02977-7. Biochem Biophys Res Commun. 2003. PMID: 12535648
The tumor microenvironment: a potential arbitrator of the tumor suppressive and promoting actions of TGFbeta.
Dumont N, Arteaga CL. Dumont N, et al. Differentiation. 2002 Dec;70(9-10):574-82. doi: 10.1046/j.1432-0436.2002.700910.x. Differentiation. 2002. PMID: 12492498 Review.
Autocrine transforming growth factor-beta signaling mediates Smad-independent motility in human cancer cells.
Dumont N, Bakin AV, Arteaga CL. Dumont N, et al. J Biol Chem. 2003 Jan 31;278(5):3275-85. doi: 10.1074/jbc.M204623200. Epub 2002 Nov 5. J Biol Chem. 2003. PMID: 12421823
Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases.
Muraoka RS, Dumont N, Ritter CA, Dugger TC, Brantley DM, Chen J, Easterly E, Roebuck LR, Ryan S, Gotwals PJ, Koteliansky V, Arteaga CL. Muraoka RS, et al. Among authors: dumont n. J Clin Invest. 2002 Jun;109(12):1551-9. doi: 10.1172/JCI15234. J Clin Invest. 2002. PMID: 12070302 Free PMC article.
Rapamycin potentiates transforming growth factor beta-induced growth arrest in nontransformed, oncogene-transformed, and human cancer cells.
Law BK, Chytil A, Dumont N, Hamilton EG, Waltner-Law ME, Aakre ME, Covington C, Moses HL. Law BK, et al. Among authors: dumont n. Mol Cell Biol. 2002 Dec;22(23):8184-98. doi: 10.1128/mcb.22.23.8184-8198.2002. Mol Cell Biol. 2002. PMID: 12417722 Free PMC article.
130 results
Jump to page
Feedback